1. Home
  2. PKST vs IRWD Comparison

PKST vs IRWD Comparison

Compare PKST & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peakstone Realty Trust

PKST

Peakstone Realty Trust

HOLD

Current Price

$20.99

Market Cap

780.2M

Sector

Real Estate

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.63

Market Cap

663.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKST
IRWD
Founded
2008
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
780.2M
663.6M
IPO Year
2014
2009

Fundamental Metrics

Financial Performance
Metric
PKST
IRWD
Price
$20.99
$3.63
Analyst Decision
Hold
Buy
Analyst Count
2
3
Target Price
$21.00
$7.67
AVG Volume (30 Days)
491.8K
2.2M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
1.91%
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.24
Revenue
$105,981,000.00
$298,276,000.00
Revenue This Year
$12.08
$57.95
Revenue Next Year
$10.03
$4.39
P/E Ratio
N/A
$13.96
Revenue Growth
N/A
8.88
52 Week Low
$11.50
$0.61
52 Week High
$21.00
$5.78

Technical Indicators

Market Signals
Indicator
PKST
IRWD
Relative Strength Index (RSI) 78.34 52.72
Support Level $20.72 $3.07
Resistance Level N/A $3.95
Average True Range (ATR) 0.02 0.21
MACD -0.02 0.00
Stochastic Oscillator 85.71 66.09

Price Performance

Historical Comparison
PKST
IRWD

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: